drugset / Trial / NCT02964195

Summary

The purpose of the study is to evaluate the efficacy of Rifaximin in the treatment of cirrhotic gastroesophageal variceal bleeding.

Timeline

Start
2016-11
Primary completion
2017-10
Completion
2018-04

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Rifaximin Other / unclassified 400 mg